CDC Panel Votes to Change Newborn Hepatitis B Vaccine Guidance

Shift in Hepatitis B Vaccine Recommendation

• 🎯 A federal advisory panel voted to change the long-standing recommendation for vaccinating newborns against Hepatitis B at birth.
• 💡 The previous guidance advised vaccinating all babies at birth, a measure that research indicates has reduced the infection rate by 99%.
• ⚠️ The new recommendation suggests administering the Hepatitis B vaccine dose only to newborns whose mothers test positive for the virus, with the series beginning at 2 months for others.

Concerns Over Potential Harm and Reversed Progress

• 📉 Doctors and organizations like the American Academy of Pediatrics express strong concerns that this change could reverse decades of progress in preventing Hepatitis B infections.
• 🏥 These infections can lead to serious health issues, including liver cancer.
• 🗣️ Several committee members voiced objections, highlighting the potential for significant harm and questioning the necessity of the change.

Opposition from Medical and Political Figures

• 🚫 The vote was 8 to 3, with some members believing the change is unnecessary and potentially harmful, calling it "disrupting for disrupting sake."
• 🏥 Republican Senator Bill Cassidy, a physician, urged the acting CDC director to reject the committee's guidance, calling the change a mistake.
• 📢 Critics argue this move aligns with the anti-vaccine movement's agenda and will not benefit public health.